<DOC>
	<DOC>NCT00756288</DOC>
	<brief_summary>Evaluating safety and efficacy of the use of topical retinoid with photodynamic therapy for the treatment of actinic keratoses.</brief_summary>
	<brief_title>Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses</brief_title>
	<detailed_description>Evaluating safety and efficacy of the use of topical retinoid with photodynamic therapy vs photodynamic therapy alone for the treatment of actinic keratoses.</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Photosensitizing Agents</mesh_term>
	<criteria>Inclusion Criteria Adults aged 1880 years old Subjects with AK lesions who will receive PDT Subjects with AK lesions in two areas other than face and scalp each with a surface area of 10cm2 or greater and at least 3 clinically diagnosed nonhypertrophic AK lesions in each Subjects in good health Subjects with willingness and the ability to understand and provide informed consent Exclusion Criteria Subjects who are pregnant or lactating Subjects with a history of cutaneous photosensitivity or porphyria, hypersensitivity to porphyrins, or photodermatosis Subjects with use of photosensitizing drugs within 1 week of study start Subjects with use of topical medications such as corticosteroids, alphahydroxyacids or retinoids 2 weeks before study entry Subjects who received previous treatment of target AKs within 4 weeks Subjects who are unable to understand the protocol or give informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Actinic Keratoses</keyword>
	<keyword>Blue light therapy</keyword>
	<keyword>photosensitizer</keyword>
	<keyword>Retinoid</keyword>
</DOC>